SR One
About SR One
SR One is the corporate venture capital arm of GlaxoSmithKline.
Investment focus
Sectors
Portfolio (3 in our database)
Odyssey TherapeuticsOdyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.Series A · $218M raisedPalleon PharmaceuticalsPalleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.Series B · $148M raisedPropeller HealthPropeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management.Acquired · $70M raised